Caribbean ECMO registry launches to track Life-Saving machine outcomes

NCT ID NCT07351435

Not yet recruiting Knowledge-focused Sponsor: University of Genova Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will collect information from 1,200 patients in the French West Indies and Guiana who received ECMO, a machine that helps the heart and lungs. Researchers aim to track survival rates and complications to better understand how ECMO works in this region. The study does not test a new drug or device, but gathers real-world data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide valuable insights into ECMO use and outcomes in the Caribbean region, potentially improving care guidelines.
What could go wrong: This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Data collection may be incomplete, limiting conclusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury acute respiratory distress syndrome acute respiratory failure cardiac arrest cardiogenic shock heart failure infectious disease with sepsis ischemic disease poisoning postoperative ventricular dysfunction pulmonary embolism respiratory failure Sepsis Shock, Cardiogenic Sickle Cell Trait

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY FAILURE ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) CARDIAC ARREST (CA) CARDIOGENIC SHOCK DREPANOCYTOSIS AND THORACIC SYNDROME INTOXICATION ISCHEMIC OR VALVULAR HEART FAILURE MALIGNANT ARRHYTHMIAS POSTCARDIOTOMY HEART FAILURE PULMONARY THROMBOEMBOLISMS SEPSIS

More trials for these conditions

Other studies related to the condition(s) this trial covers.